In the treatment of ALL, we are currently focusing on ways of helping the patient's immune system fight the leukemic cells. Outpatient Services Available Patients with ALL who desire consultation services or second opinions are seen in the Oncology Center Outpatient Department . Inpatient Services Available Patients with ALL undergoing intensive chemotherapy are treated on a 21 bed unit specialized for the aggressive treatment of patients with hematologic malignancies. The nursing staff is highly trained in the care of leukemic patients and in critical care. The unit is capable of providing conventional and intensive care.
All rooms are private with special air-filtering to decrease the risk of infections.
Patients undergoing bone marrow transplantation are hospitalized on a separate specialty unit or are treated in our new IPOP unit . New Therapy Highlight ALL appears to disguise itself from the body's immune system by making the immune system tolerant to the differences between normal and leukemic cells. We are studying the ability of the administration of cyclosporine A to cause the immune system to recognize and fight ALL in patients receiving consolidation chemotherapy. Click here for more information about this trial . Faculty Dr. Hayden Braine runs our platelet pheresis program and attends on our inpatient Hematologic Malignancy Unit.